Boehringer Ingelheim begins VOLTAIRE-X interchangeability study of adalimumab biosimilar July 31, 2017
UCB files for U.S. and E.U. approvals for Cimzia in moderate to severe chronic plaque psoriasis July 26, 2017
UCB announces promising phase IIb data for bimekizumab in patients with chronic plaque psoriasis July 25, 2017
Council of Scientific and Industrial Research divulges compounds for vitiligo treatment July 24, 2017
RSS